The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 16 06 2024
accepted: 08 10 2024
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 17 10 2024
Statut: epublish

Résumé

Bacteriophages are influential within the human gut microbiota, yet they remain understudied relative to bacteria. This is a limitation of studies on fecal microbiota transplantation (FMT) where bacteriophages likely influence outcome. Here, using metagenomics, we profile phage populations - the phageome - in individuals recruited into two double-blind randomized trials of FMT in ulcerative colitis. We leverage the trial designs to observe that phage populations behave similarly to bacterial populations, showing temporal stability in health, dysbiosis in active disease, modulation by antibiotic treatment and by FMT. We identify a donor bacteriophage putatively associated with disease remission, which on genomic analysis was found integrated in a bacterium classified to Oscillospiraceae, previously isolated from a centenarian and predicted to produce vitamin B complex except B12. Our study provides an in-depth assessment of phage populations during different states and suggests that bacteriophage tracking has utility in identifying determinants of disease activity and resolution.

Identifiants

pubmed: 39420033
doi: 10.1038/s41467-024-53454-4
pii: 10.1038/s41467-024-53454-4
doi:

Substances chimiques

Anti-Bacterial Agents 0
Biomarkers 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

8979

Subventions

Organisme : Crohn's and Colitis Foundation (Crohn's & Colitis Foundation)
ID : 988415
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : APP2011047
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : Investigator grant
Organisme : University of New South Wales (UNSW Australia)
ID : Scientia fellowship

Informations de copyright

© 2024. The Author(s).

Références

Gregory, A. C. et al. The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe 28, 724–740 (2020).
pubmed: 32841606 pmcid: 7443397 doi: 10.1016/j.chom.2020.08.003
Shkoporov, A. N. & Hill, C. Bacteriophages of the human gut: the “Known Unknown” of the microbiome. Cell Host Microbe 25, 195–209 (2019).
pubmed: 30763534 doi: 10.1016/j.chom.2019.01.017
Zuppi, M., Hendrickson, H. L., O’Sullivan, J. M. & Vatanen, T. Phages in the gut ecosystem. Front. Cell Infect. Microbiol. 11, 822562 (2021).
pubmed: 35059329 doi: 10.3389/fcimb.2021.822562
Tiamani, K. et al. The role of virome in the gastrointestinal tract and beyond. FEMS Microbiol. Rev. 46 (2022).
Lim, E. S. et al. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat. Med. 21, 1228–1234 (2015).
pubmed: 26366711 pmcid: 4710368 doi: 10.1038/nm.3950
Reyes, A. et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334–338 (2010).
pubmed: 20631792 pmcid: 2919852 doi: 10.1038/nature09199
Shkoporov, A. N. et al. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe 26, 527–541 (2019).
pubmed: 31600503 doi: 10.1016/j.chom.2019.09.009
Clooney, A. G. et al. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host Microbe 26, 764–778 (2019).
pubmed: 31757768 doi: 10.1016/j.chom.2019.10.009
Manrique, P. et al. Healthy human gut phageome. Proc. Natl Acad. Sci. Usa. 113, 10400–10405 (2016).
pubmed: 27573828 pmcid: 5027468 doi: 10.1073/pnas.1601060113
Bethlehem, L. et al. Microbiota therapeutics for inflammatory bowel disease: the way forward. Lancet Gastroenterol. Hepatol. 9, 476–486 (2024).
pubmed: 38604201 doi: 10.1016/S2468-1253(23)00441-7
Costello, S. P. et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment. Pharmacol. Ther. 46, 213–224 (2017).
pubmed: 28612983 doi: 10.1111/apt.14173
Green, J. E. et al. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 12, 1–25 (2020).
doi: 10.1080/19490976.2020.1854640
Lai, C. Y. et al. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment. Pharmacol. Ther. 49, 354–363 (2019).
pubmed: 30628108 doi: 10.1111/apt.15116
Paramsothy, S. et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. J. Crohns Colitis 11, 1180–1199 (2017).
pubmed: 28486648 doi: 10.1093/ecco-jcc/jjx063
Kaakoush, N. O. Fecal transplants as a microbiome-based therapeutic. Curr. Opin. Microbiol. 56, 16–23 (2020).
pubmed: 32615390 doi: 10.1016/j.mib.2020.05.008
Conceicao-Neto, N. et al. Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC. Gut 67, 1558–1559 (2018).
pubmed: 29066574 doi: 10.1136/gutjnl-2017-315281
Gogokhia, L. et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe 25, 285–299 (2019).
pubmed: 30763538 pmcid: 6885004 doi: 10.1016/j.chom.2019.01.008
Draper, L. A. et al. Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation. Microbiome 6, 220 (2018).
pubmed: 30526683 pmcid: 6288847 doi: 10.1186/s40168-018-0598-x
Fujimoto, K. et al. Functional restoration of bacteriomes and viromes by fecal microbiota transplantation. Gastroenterology 160, 2089–2102 (2021).
pubmed: 33577875 doi: 10.1053/j.gastro.2021.02.013
Ott, S. J. et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152, 799–811 (2017).
pubmed: 27866880 doi: 10.1053/j.gastro.2016.11.010
Liu, Q. et al. Faecal microbiota transplantations and the role of bacteriophages. Clin. Microbiol. Infect. 29, 689–694 (2023).
pubmed: 36414201 doi: 10.1016/j.cmi.2022.11.012
Zuo, T. et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut 67, 634–643 (2018).
pubmed: 28539351
Manrique, P. et al. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome. Gut Microbes 13, 1–15 (2021).
pubmed: 33794724 doi: 10.1080/19490976.2021.1897217
Wortelboer, K. et al. Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety. Nat. Commun. 14, 5600 (2023).
pubmed: 37699894 pmcid: 10497675 doi: 10.1038/s41467-023-41329-z
Haifer, C. et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol. Hepatol. 7, 141–151 (2022).
pubmed: 34863330 doi: 10.1016/S2468-1253(21)00400-3
Sato, Y. et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature 599, 458–464 (2021).
pubmed: 34325466 doi: 10.1038/s41586-021-03832-5
Paramsothy, S. et al. Donor recruitment for fecal microbiota transplantation. Inflamm. Bowel Dis. 21, 1600–1606 (2015).
pubmed: 26070003 doi: 10.1097/MIB.0000000000000405
Bloom, S. M. et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9, 390–403 (2011).
pubmed: 21575910 pmcid: 3241010 doi: 10.1016/j.chom.2011.04.009
Wang, L. et al. Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori. Nat. Commun. 14, 2196 (2023).
pubmed: 37069161 pmcid: 10110541 doi: 10.1038/s41467-023-37975-y
Zuppi, M. et al. Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity. Microbiome 12, 122 (2024).
pubmed: 38970126 pmcid: 11227244 doi: 10.1186/s40168-024-01833-w
Wan, Z. et al. Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health. Front. Nutr. 9, 1031502 (2022).
pubmed: 36583209 pmcid: 9792504 doi: 10.3389/fnut.2022.1031502
Chen, C. et al. Vitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation. Cell Rep. 41, 111741 (2022).
pubmed: 36450257 doi: 10.1016/j.celrep.2022.111741
Franzosa, E. A. et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4, 293–305 (2019).
pubmed: 30531976 doi: 10.1038/s41564-018-0306-4
Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662 (2019).
pmcid: 6650278 doi: 10.1038/s41586-019-1237-9
Vich Vila, A. et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci. Transl. Med. 10, eaap8914 (2018).
pubmed: 30567928 doi: 10.1126/scitranslmed.aap8914
Pan, Y. et al. Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis. Nutrients 9, 382 (2017).
pubmed: 28406440 pmcid: 5409721 doi: 10.3390/nu9040382
Shkoporov, A. N. et al. Reproducible protocols for metagenomic analysis of human faecal phageomes. Microbiome 6, 68 (2018).
pubmed: 29631623 pmcid: 5892011 doi: 10.1186/s40168-018-0446-z
Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218–1228 (2017).
pubmed: 28214091 doi: 10.1016/S0140-6736(17)30182-4
Paramsothy, S. et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology 156, 1440–1454 (2019).
pubmed: 30529583 doi: 10.1053/j.gastro.2018.12.001
Haifer, C. et al. Microbial determinants of effective donors in faecal microbiota transplantation for UC. Gut 72, 90–100 (2023).
doi: 10.1136/gutjnl-2022-327742
Pandolfo, M., Telatin, A., Lazzari, G., Adriaenssens, E. M. & Vitulo, N. MetaPhage: an automated pipeline for analyzing, annotating, and classifying bacteriophages in metagenomics sequencing data. mSystems 7, e0074122 (2022).
pubmed: 36069454 doi: 10.1128/msystems.00741-22
Li, D., Liu, C. M., Luo, R., Sadakane, K. & Lam, T. W. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics 31, 1674–1676 (2015).
doi: 10.1093/bioinformatics/btv033
Mikheenko, A., Saveliev, V. & Gurevich, A. MetaQUAST: evaluation of metagenome assemblies. Bioinformatics 32, 1088–1090 (2016).
pubmed: 26614127 doi: 10.1093/bioinformatics/btv697
Ren, J. et al. Identifying viruses from metagenomic data using deep learning. Quant. Biol. 8, 64–77 (2020).
pubmed: 34084563 pmcid: 8172088 doi: 10.1007/s40484-019-0187-4
Kieft, K., Zhou, Z. & Anantharaman, K. VIBRANT: automated recovery, annotation and curation of microbial viruses, and evaluation of viral community function from genomic sequences. Microbiome 8, 90 (2020).
pubmed: 32522236 pmcid: 7288430 doi: 10.1186/s40168-020-00867-0
Starikova, E. V. et al. Phigaro: high-throughput prophage sequence annotation. Bioinformatics 36, 3882–3884 (2020).
pubmed: 32311023 doi: 10.1093/bioinformatics/btaa250
Guo, J. et al. VirSorter2: a multi-classifier, expert-guided approach to detect diverse DNA and RNA viruses. Microbiome 9, 37 (2021).
pubmed: 33522966 pmcid: 7852108 doi: 10.1186/s40168-020-00990-y
Ren, J., Ahlgren, N. A., Lu, Y. Y., Fuhrman, J. A. & Sun, F. VirFinder: a novel k-mer based tool for identifying viral sequences from assembled metagenomic data. Microbiome 5, 69 (2017).
pubmed: 28683828 pmcid: 5501583 doi: 10.1186/s40168-017-0283-5
Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150–3152 (2012).
pubmed: 23060610 pmcid: 3516142 doi: 10.1093/bioinformatics/bts565
Nayfach, S. et al. CheckV assesses the quality and completeness of metagenome-assembled viral genomes. Nat. Biotechnol. 39, 578–585 (2021).
pubmed: 33349699 doi: 10.1038/s41587-020-00774-7
Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938–2940 (2017).
pubmed: 28645171 pmcid: 5870712 doi: 10.1093/bioinformatics/btx364
Langmead, B., Wilks, C., Antonescu, V. & Charles, R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics 35, 421–432 (2019).
pubmed: 30020410 doi: 10.1093/bioinformatics/bty648
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Birolo, G. & Telatin, A. BamToCov: an efficient toolkit for sequence coverage calculations. Bioinformatics 38, 2617–2618 (2022).
pubmed: 35199151 pmcid: 9048650 doi: 10.1093/bioinformatics/btac125
Hyatt, D. et al. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinforma. 11, 119 (2010).
doi: 10.1186/1471-2105-11-119
Buchfink, B., Xie, C. & Huson, D. H. Fast and sensitive protein alignment using DIAMOND. Nat. Methods 12, 59–60 (2015).
pubmed: 25402007 doi: 10.1038/nmeth.3176
Bin Jang, H. et al. Taxonomic assignment of uncultivated prokaryotic virus genomes is enabled by gene-sharing networks. Nat. Biotechnol. 37, 632–639 (2019).
doi: 10.1038/s41587-019-0100-8
Jiang, J. Z. et al. Virus classification for viral genomic fragments using PhaGCN2. Brief. Bioinform. 24, bbac505 (2023).
pubmed: 36464489 doi: 10.1093/bib/bbac505
Bastiaanssen, T. F. S., Quinn, T. P. & Loughman, A. Bugs as features (part 1): concepts and foundations for the compositional data analysis of the microbiome–gut–brain axis. Nat. Ment. Health 1, 930–938 (2023).
doi: 10.1038/s44220-023-00148-3
Yang, L. & Chen, J. A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions. Microbiome 10, 130 (2022).
pubmed: 35986393 pmcid: 9392415 doi: 10.1186/s40168-022-01320-0
Roux, S. et al. iPHoP: An integrated machine learning framework to maximize host prediction for metagenome-derived viruses of archaea and bacteria. PLoS Biol. 21, e3002083 (2023).
pubmed: 37083735 pmcid: 10155999 doi: 10.1371/journal.pbio.3002083
Shang, J., Peng, C., Liao, H., Tang, X. & Sun, Y. PhaBOX: a web server for identifying and characterizing phage contigs in metagenomic data. Bioinform. Adv. 3, vbad101 (2023).
pubmed: 37641717 pmcid: 10460485 doi: 10.1093/bioadv/vbad101
Kolmogorov, M. et al. metaFlye: scalable long-read metagenome assembly using repeat graphs. Nat. Methods 17, 1103–1110 (2020).
pubmed: 33020656 pmcid: 10699202 doi: 10.1038/s41592-020-00971-x
Wick, R. R. & Holt, K. E. Polypolish: short-read polishing of long-read bacterial genome assemblies. PLoS Comput. Biol. 18, e1009802 (2022).
pubmed: 35073327 pmcid: 8812927 doi: 10.1371/journal.pcbi.1009802
Zimin, A. V. & Salzberg, S. L. The genome polishing tool POLCA makes fast and accurate corrections in genome assemblies. PLoS Comput. Biol. 16, e1007981 (2020).
pubmed: 32589667 pmcid: 7347232 doi: 10.1371/journal.pcbi.1007981
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv https://doi.org/10.48550/arXiv.1303.3997 (2013).
Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).
pubmed: 21988835 pmcid: 3261699 doi: 10.1038/msb.2011.75
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
pubmed: 2231712 doi: 10.1016/S0022-2836(05)80360-2
Grant, J. R. et al. Proksee: in-depth characterization and visualization of bacterial genomes. Nucleic Acids Res. 51, W484–W492 (2023).
pubmed: 37140037 pmcid: 10320063 doi: 10.1093/nar/gkad326
Arkin, A. P. et al. KBase: The United States Department of Energy Systems Biology Knowledgebase. Nat. Biotechnol. 36, 566–569 (2018).
pubmed: 29979655 pmcid: 6870991 doi: 10.1038/nbt.4163
Henry, C. S. et al. High-throughput generation, optimization and analysis of genome-scale metabolic models. Nat. Biotechnol. 28, 977–982 (2010).
pubmed: 20802497 doi: 10.1038/nbt.1672
Lopez-Ibanez, J., Pazos, F. & Chagoyen, M. MBROLE 2.0-functional enrichment of chemical compounds. Nucleic Acids Res. 44, W201–W204 (2016).
pubmed: 27084944 pmcid: 4987872 doi: 10.1093/nar/gkw253

Auteurs

Marwan E Majzoub (ME)

School of Biomedical Sciences, Faculty of Medicine and Health, UNSW, Sydney, Australia.

Sudarshan Paramsothy (S)

Concord Clinical School, University of Sydney, Sydney, Australia.
Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, Australia.

Craig Haifer (C)

School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, Australia.
Department of Gastroenterology, St Vincent's Hospital, Sydney, Australia.

Rohit Parthasarathy (R)

School of Biomedical Sciences, Faculty of Medicine and Health, UNSW, Sydney, Australia.

Thomas J Borody (TJ)

Centre for Digestive Diseases, Sydney, Australia.

Rupert W Leong (RW)

Concord Clinical School, University of Sydney, Sydney, Australia.
Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, Australia.

Michael A Kamm (MA)

Department of Gastroenterology, St Vincent's Hospital, Melbourne, Australia.
Department of Medicine, University of Melbourne, Melbourne, Australia.

Nadeem O Kaakoush (NO)

School of Biomedical Sciences, Faculty of Medicine and Health, UNSW, Sydney, Australia. n.kaakoush@unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH